Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Spencer Laing"'
Publikováno v:
Scientific Studies of Reading. 25:486-503
We assessed nonword repetition (NWR) skills in 7–9 year-old children with dyslexia (dyslexia-only), developmental language disorder (DLD-only), co-occurring DLD+dyslexia, and typical development (T...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a5f291bf632fdbfcda9ed4b20a638ea
https://doi.org/10.1080/10888438.2020.1849223
https://doi.org/10.1080/10888438.2020.1849223
Autor:
Faith Brianne Buchanan, Winnie W. Y. Lau, Kaitlin Morrison, Natalie S Grover, Robert S. Hagan, Barbara Savoldo, Spencer Laing, James M. Coghill, John A. West, Matthew C. Foster, Gianpietro Dotti, Paul M. Armistead, Clio Rubinos, Catherine Cheng, Aaron E. Foster, Jonathan S. Serody, Anastasia Ivanova
Publikováno v:
Blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b2086bc61ec56eab71283b6ee443fc
https://pubmed.ncbi.nlm.nih.gov/33624095
https://pubmed.ncbi.nlm.nih.gov/33624095
Autor:
Mary B Seegars, Natalie S Grover, Marcie L. Riches, Anastasia Ivanova, Spencer Laing, Thomas C. Shea, Gianpietro Dotti, Jonathan S. Serody, Catherine Cheng, Barbara Savoldo
Publikováno v:
Transplantation and Cellular Therapy. 27:S65-S66
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c346568d5eedfe5975626ff5a6dbd28
https://doi.org/10.1016/s2666-6367(21)00093-2
https://doi.org/10.1016/s2666-6367(21)00093-2
Autor:
Philip A. Roehrs, Katarzyna Jamieson, J. Kaitlin Morrison, Gianpietro Dotti, Barbara Savoldo, Natalie S Grover, George E Hucks, Paul M. Armistead, Spencer Laing, Matthew C. Foster, Faith Brianne Buchanan, Jonathan S. Serody, Catherine Cheng
Publikováno v:
Blood. 136:36-37
Introduction: CAR-T cells targeting the CD19 antigen are approved to treat children and young adults with relapsed and refractory B-cell ALL, in whom response rates are >80%. Acute toxicities, including cytokine release syndrome (CRS) and immune effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e5d1883c62aed5906cbacd4b99ec18e
https://doi.org/10.1182/blood-2020-139051
https://doi.org/10.1182/blood-2020-139051
Autor:
J. Kaitlin Morrison, Barbara Savoldo, Gianpietro Dotti, Anne W. Beaven, Spencer Laing, Jonathan S. Serody, Timothy J Voorhees, Catherine Cheng, Natalie S Grover, Steven I. Park
Publikováno v:
Blood. 134:3233-3233
Background: The safety and efficacy of treating pts with relapsed/refractory (r/r) CD30+ lymphomas with chimeric receptor modified T cells targeting the CD30 molecule (CD30.CAR-T) has been recently demonstrated (Grover et al., ASH 2018). Expression o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ee692010ca65570e467489095362c49
https://doi.org/10.1182/blood-2019-122846
https://doi.org/10.1182/blood-2019-122846
Autor:
Kimberly Wehner, Spencer Laing, Anne W. Beaven, Shaw Scott, Anastasia Ivanova, Steven I. Park, Maurice Alexander, Desirae Shelley, Erin Crecelius, Gianpietro Dotti, Ashley Zanter, Paul Eldridge, J. Kaitlin Morrison, Alicia Pinto, Christopher Dittus, Faith Brianne Buchanan, John A. West, Angela Spruill, Natalie S Grover, Megan McElfresh, Barbara Savoldo, Elizabeth Sharf, Catherine Cheng, Thomas C. Shea, Jonathan S. Serody, Kathryn McKay, Emily Herrick Kassam, Deborah L. Covington
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S66
Introduction Treatment with chimeric antigen receptor modified T cells targeting CD30 (CD30.CAR-Ts) without lymphodepletion was found to be safe with preliminary efficacy in patients (pts) with relapsed/refractory (r/r) CD30+ lymphomas (Ramos et al.,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8dc2eec7efee839907ec04c9b7b6587
https://doi.org/10.1016/j.bbmt.2018.12.149
https://doi.org/10.1016/j.bbmt.2018.12.149
Autor:
Jonathan S. Serody, Angela Spruill, Erin Crecelius, Kathryn McKay, Emily Herrick Kassam, Faith Brianne Buchanan, Thomas C. Shea, Natalie S Grover, Deborah L. Covington, Kimberly Wehner, S. Elizabeth Sharf, Anastasia Ivanova, Catherine Cheng, Paul Eldridge, Steven I. Park, Shaw Scott, Ashley Zanter, J. Kaitlin Morrison, Christopher Dittus, Gianpietro Dotti, Alicia Pinto, Anne W. Beaven, Barbara Savoldo, Spencer Laing, Desirae Shelley, Megan McElfresh, Maurice Alexander, John A. West
Publikováno v:
Blood. 132:681-681
Background: Infusion of chimeric antigen receptor modified T cells targeting the CD30 molecule and encoding the CD28 endodomain (CD30.CAR-Ts) in the absence of lymphodepleting chemotherapy has been shown to be safe with responses seen in patients (pt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e8c111cc095aeff1bc38cefe28dd9a5
https://doi.org/10.1182/blood-2018-99-113534
https://doi.org/10.1182/blood-2018-99-113534